Krishna Institute of Medical Sciences Share Price

Krishna Institute of Medical Sciences, or KIMS, is a corporate healthcare group, with hospitals in Telangana, Andhra Pradesh and Maharashtra. It provides multi-disciplinary integrated healthcare services with a focus on tertiary and quaternary healthcare.

KIMS was initially established as Jagjit Singh and Sons Private Limited in 1973 in Mumbai. Later, in 2004, the company's name was changed to Krishna Institute of Medical Sciences Private Limited. Until 2003, Jagjit Singh and some of his family members solely owned, managed and controlled the company. In February 2003, certain promoters of the company, including Dr Bhaskar Rao Bollineni and Krishnaiah Bollineni, along with other individuals and entities, acquired the entire equity share capital of the company.

KIMS began its journey in Nellore, Andhra Pradesh, establishing its oldest hospital with a capacity of about 200 beds. Two years later, in 2002, the group expanded its presence by inaugurating another hospital in Rajahmundry, Andhra Pradesh. KIMS hospital, located in Secunderabad, was established in 2004 and has a capacity of 1,000 beds, as per a CRISIL Report.

The main hospitals in Secunderabad and Rajahmundry have received accreditation from the National Accreditation Board for Hospitals and Healthcare Providers India (NABH).

Over the years, the group ventured into various cities in Andhra Pradesh and Maharashtra, apart from Telangana. In 2021, KIMS acquired a stake in Hyderabad-based Sunshine Hospitals. The following year, in 2022, it expanded its footprint by signing an MoU with Dr Raj Nagarkar, a surgical oncologist in western Maharashtra, to establish KIMS Manavata Hospital, a multi-specialty facility in Nashik with a total bed capacity of 325. KIMS also acquired a majority stake in Kingsway Hospitals in Nagpur in 2022. KIMS went public in 2021 with its initial public offering (IPO), transitioning into a public company.

The market capitalisation of Krishna Institute of Medical Sciences Limited is over ₹18,300 crore as of February 28, 2024. KIMS share price has gained over 70% in the last one year.

Business Operations

KIMS manages 12 multispecialty hospitals, providing a wide array of healthcare services across more than 40 specialities and super specialities. These include cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and childcare.

The Sunshine Hospitals which came into the hands of KIMS generated a revenue contribution of 19%. The KIMS SUNSHINE will be shifted soon to the company’s premises which will add 300 new beds. FY 2023 FY marked the group's foray into Maharashtra at important centres like Nagpur and Nashik through strategic alliances. The Nagpur unit brought another 330+ beds.

The company is all set to enter Karnataka in the ensuing year with a 250-bed hospital in the heart of Bengaluru. There are immediate plans to expand its wings to Thane, Mumbai in the next year. All these initiatives will lead to a doubling of its capacity to 8,000 beds in the next 2-3 years spanning across the states of Telangana, AP, Maharashtra and Karnataka.

Krishna Institute of Medical Sciences Financial Highlights

• Revenue: Krishna Institute of Medical Sciences reported revenue of ₹3,930.80 crore in FY26 vs ₹3,066.90 crore in FY25. It showed an increase of 28.17% on a yearly basis.
• Operating Profit: Krishna Institute of Medical Sciences reported an operating profit of ₹333.90 crore in FY26 vs ₹557.90 crore in FY25. It showed a decrease of 40.15% on a year-on-year basis.
• Net Profit: Krishna Institute of Medical Sciences reported a net profit of ₹242.00 crore in FY26 vs ₹414.50 crore in FY25. It showed a decrease of 41.62% on a yearly basis.

Krishna Institute of Medical Sciences Quarterly Result Highlights

• Krishna Institute of Medical Sciences reported revenue of ₹1,195.90 crore in Jun 2026, compared with ₹1,084.30 crore in Mar 2026, representing an increase of 10.29% on a quarter-on-quarter (QoQ) basis.
• Krishna Institute of Medical Sciences reported an operating profit of ₹56.60 crore in Jun 2026, compared with ₹54.80 crore in Mar 2026, representing an increase of 3.28% on a quarter-on-quarter (QoQ) basis.
• Krishna Institute of Medical Sciences reported a profit of ₹37.40 crore in Jun 2026, compared with ₹33.10 crore in Mar 2026, reflecting an increase of 12.99% on a QoQ basis.
• The earnings per share (EPS) of Krishna Institute of Medical Sciences stood at ₹6.03 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.